RNSG 1301 - Unit I exam study guide
questions with correct answers
1. A ||nurse ||is ||assessing ||the ||client's ||home ||medication ||use. ||After ||listening ||to ||the ||client ||list
||current ||medications, ||the ||nurse ||asks ||what ||priority ||question? ||- ||✔◻✔◻D) ||"Do ||you ||take ||any
||over-the-counter ||medications?"
2. Which ||classification ||applies ||to ||Morphine? ||- ||✔◻✔◻A) ||central ||nervous ||system ||depressant
3. While ||studying ||for ||the ||test, ||a ||nursing ||student ||encounters ||the ||following ||drug: ||ibuprofen
||(Motrin). ||What ||does ||the ||nursing ||student ||identify ||the ||name ||ibuprofen ||as? ||- ||✔◻✔◻A)
||The ||generic ||name
4. A ||nurse ||is ||teaching ||the ||client ||about ||the ||use ||of ||over ||the ||counter ||(OTC) ||drugs. ||Which
||statement ||best ||informs ||the ||client ||about ||their ||use? ||- ||✔◻✔◻D) ||"OTC ||drugs ||need ||to ||be
||taken ||with ||caution; ||they ||can ||mask ||the ||signs ||and ||symptoms ||of ||an ||underlying ||disease ||and
||interfere ||with ||prescription ||drug ||therapy."
5. Which ||term ||is ||used ||to ||describe ||the ||study ||of ||drugs ||and ||their ||action ||on ||living ||organism? ||-
||✔◻✔◻A) ||Pharmacology
6. A ||health ||care ||facility ||is ||complying ||with ||the ||mandates ||of ||The ||Drug ||Enforcement
||Administration ||(DEA) ||concerning ||Schedule ||II ||medications ||when ||implementing ||which ||nursing
||intervention? ||Select ||all ||that ||apply. ||- ||✔◻✔◻A) ||Assess ||to ||narcotics ||is ||controlled ||by ||key ||or
||codes.
B) Narcotics ||are ||administered ||by ||prescriptions ||only.
D) The ||administration ||of ||individual ||narcotic ||doses ||are ||recorded ||in ||specific ||unit ||documentation.
E) Any ||recognized ||discrepancy ||involving ||a ||narcotic ||must ||be ||reported ||to ||the ||appropriate
||facility ||authority,
7. Which ||organization ||is ||responsible ||for ||approving ||new ||drugs ||in ||the ||United ||States? ||-
||✔◻✔◻C) ||Food ||and ||Drug ||Administration ||(FDA)
, 8. A ||nursing ||student ||in ||a ||pharmacology ||class ||should ||be ||encouraged ||to ||study ||the ||medications
||according ||to ||which ||categorization? ||Select ||all ||that ||apply. ||- ||✔◻✔◻A) ||prototype
E) ||therapeutic ||classification
9. A ||client ||is ||confused ||and ||has ||stated ||to ||the ||nurse, ||"I ||wasn't ||sure ||whether ||I'm ||supposed ||to
||take ||Tylenol ||or ||acetaminophen." ||To ||best ||address ||the ||client's ||concern, ||the ||nurse ||should ||base
||the ||response ||on ||what ||information ||concerning ||generic ||and ||trade ||names? ||- ||✔◻✔◻B) ||A
||generic ||name ||is ||independent ||of ||any ||particular ||drug ||manufacturer.
10. A ||client's ||current ||medication ||administration ||record ||includes ||a ||drug ||that ||the ||nurse
||recognizes ||as ||an ||Institute ||for ||Safe ||Medication ||Practices ||(ISMP) ||high-alert ||medication. ||This
||designation ||signals ||the ||nurse ||to ||what ||characteristic ||of ||the ||drug? ||- ||✔◻✔◻D) ||Administration
||errors ||carry ||a ||heightened ||risk ||of ||causing ||significant ||client ||harm.
11. A ||hospital ||nurse ||is ||vigilant ||in ||ensuring ||the ||safe ||use ||of ||medications ||and ||consistently ||applies
||the ||rights ||of ||medication ||administration. ||What ||are ||the ||rights ||of ||medication ||administration?
||Select ||all ||that ||apply. ||-
✔◻✔◻A) ||right ||to ||refuse ||prescribed ||medication
B) right ||route ||for ||effective ||medication ||therapy
C) right ||to ||effective ||medication ||education
D) right ||evaluation ||of ||expected ||results
12. The ||nurse ||is ||caring ||for ||an ||older ||adult ||who ||needs ||to ||know ||that ||drugs, ||even ||when ||taken
||correctly, ||can ||produce ||negative ||or ||unexpected ||effects. ||The ||nurse ||should ||address ||what ||topic
||during ||health ||education? ||-
✔◻✔◻C) ||Adverse ||effects
13. Which ||process ||occurs ||between ||the ||time ||the ||drug ||enters ||the ||body ||and ||the ||time ||that ||it
||enters ||the ||bloodstream? ||- ||✔◻✔◻A) ||absorption
14. Which ||site ||is ||preferred ||when ||consideration ||must ||be ||made ||to ||identifying ||an
||exceptionally ||large ||surface ||area ||for ||drug ||absorption? ||- ||✔◻✔◻D) ||lungs
questions with correct answers
1. A ||nurse ||is ||assessing ||the ||client's ||home ||medication ||use. ||After ||listening ||to ||the ||client ||list
||current ||medications, ||the ||nurse ||asks ||what ||priority ||question? ||- ||✔◻✔◻D) ||"Do ||you ||take ||any
||over-the-counter ||medications?"
2. Which ||classification ||applies ||to ||Morphine? ||- ||✔◻✔◻A) ||central ||nervous ||system ||depressant
3. While ||studying ||for ||the ||test, ||a ||nursing ||student ||encounters ||the ||following ||drug: ||ibuprofen
||(Motrin). ||What ||does ||the ||nursing ||student ||identify ||the ||name ||ibuprofen ||as? ||- ||✔◻✔◻A)
||The ||generic ||name
4. A ||nurse ||is ||teaching ||the ||client ||about ||the ||use ||of ||over ||the ||counter ||(OTC) ||drugs. ||Which
||statement ||best ||informs ||the ||client ||about ||their ||use? ||- ||✔◻✔◻D) ||"OTC ||drugs ||need ||to ||be
||taken ||with ||caution; ||they ||can ||mask ||the ||signs ||and ||symptoms ||of ||an ||underlying ||disease ||and
||interfere ||with ||prescription ||drug ||therapy."
5. Which ||term ||is ||used ||to ||describe ||the ||study ||of ||drugs ||and ||their ||action ||on ||living ||organism? ||-
||✔◻✔◻A) ||Pharmacology
6. A ||health ||care ||facility ||is ||complying ||with ||the ||mandates ||of ||The ||Drug ||Enforcement
||Administration ||(DEA) ||concerning ||Schedule ||II ||medications ||when ||implementing ||which ||nursing
||intervention? ||Select ||all ||that ||apply. ||- ||✔◻✔◻A) ||Assess ||to ||narcotics ||is ||controlled ||by ||key ||or
||codes.
B) Narcotics ||are ||administered ||by ||prescriptions ||only.
D) The ||administration ||of ||individual ||narcotic ||doses ||are ||recorded ||in ||specific ||unit ||documentation.
E) Any ||recognized ||discrepancy ||involving ||a ||narcotic ||must ||be ||reported ||to ||the ||appropriate
||facility ||authority,
7. Which ||organization ||is ||responsible ||for ||approving ||new ||drugs ||in ||the ||United ||States? ||-
||✔◻✔◻C) ||Food ||and ||Drug ||Administration ||(FDA)
, 8. A ||nursing ||student ||in ||a ||pharmacology ||class ||should ||be ||encouraged ||to ||study ||the ||medications
||according ||to ||which ||categorization? ||Select ||all ||that ||apply. ||- ||✔◻✔◻A) ||prototype
E) ||therapeutic ||classification
9. A ||client ||is ||confused ||and ||has ||stated ||to ||the ||nurse, ||"I ||wasn't ||sure ||whether ||I'm ||supposed ||to
||take ||Tylenol ||or ||acetaminophen." ||To ||best ||address ||the ||client's ||concern, ||the ||nurse ||should ||base
||the ||response ||on ||what ||information ||concerning ||generic ||and ||trade ||names? ||- ||✔◻✔◻B) ||A
||generic ||name ||is ||independent ||of ||any ||particular ||drug ||manufacturer.
10. A ||client's ||current ||medication ||administration ||record ||includes ||a ||drug ||that ||the ||nurse
||recognizes ||as ||an ||Institute ||for ||Safe ||Medication ||Practices ||(ISMP) ||high-alert ||medication. ||This
||designation ||signals ||the ||nurse ||to ||what ||characteristic ||of ||the ||drug? ||- ||✔◻✔◻D) ||Administration
||errors ||carry ||a ||heightened ||risk ||of ||causing ||significant ||client ||harm.
11. A ||hospital ||nurse ||is ||vigilant ||in ||ensuring ||the ||safe ||use ||of ||medications ||and ||consistently ||applies
||the ||rights ||of ||medication ||administration. ||What ||are ||the ||rights ||of ||medication ||administration?
||Select ||all ||that ||apply. ||-
✔◻✔◻A) ||right ||to ||refuse ||prescribed ||medication
B) right ||route ||for ||effective ||medication ||therapy
C) right ||to ||effective ||medication ||education
D) right ||evaluation ||of ||expected ||results
12. The ||nurse ||is ||caring ||for ||an ||older ||adult ||who ||needs ||to ||know ||that ||drugs, ||even ||when ||taken
||correctly, ||can ||produce ||negative ||or ||unexpected ||effects. ||The ||nurse ||should ||address ||what ||topic
||during ||health ||education? ||-
✔◻✔◻C) ||Adverse ||effects
13. Which ||process ||occurs ||between ||the ||time ||the ||drug ||enters ||the ||body ||and ||the ||time ||that ||it
||enters ||the ||bloodstream? ||- ||✔◻✔◻A) ||absorption
14. Which ||site ||is ||preferred ||when ||consideration ||must ||be ||made ||to ||identifying ||an
||exceptionally ||large ||surface ||area ||for ||drug ||absorption? ||- ||✔◻✔◻D) ||lungs
